De Angel, Rebecca E

Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model. [electronic resource] - Cancer biology & therapy Apr 2013 - 357-64 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1555-8576

10.4161/cbt.23623 doi


Animals
Antimetabolites, Antineoplastic--pharmacology
Cell Line, Tumor
Deoxycytidine--analogs & derivatives
Disease Models, Animal
Drug Resistance, Neoplasm
Female
Mammary Neoplasms, Experimental--drug therapy
Mice
Mice, Inbred C57BL
Nanoparticles--administration & dosage
Obesity--physiopathology
Postmenopause
Random Allocation
Gemcitabine